MSAC Research Subcommittee

Amr Sawalha, MD   Amr Sawalha, MD, Chair
Associate Professor of Medicine
University of Michigan Medical School
Ann Arbor, MI
Graciela S. Alarcón, MD, MPH   Graciela S. Alarcón, MD, MPH
Jane Knight Lowe Chair of Medicine in Rheumatology
University of Alabama at Birmingham
Birmingham, AL
Anca D. Askanase, MD, MPH   Anca D. Askanase, MD, MPH
Assistant Professor
New York University School of Medicine      
New York University Hospital for Joint Diseases
Seligman Center for Advanced Therapeutics
New York, NY
Hermine I. Brunner, MD, MSc, MBA   Hermine I. Brunner, MD, MSc, MBA
Professor of Pediatrics
Cincinnati Children's Hospital Medical Center
Cincinnati, OH
Eliza F. Chakravarty, MD, MS   Eliza F. Chakravarty, MD, MS
Associate Member
Oklahoma Medical Research Foundation
Oklahoma City, Oklahoma
  Glinda S. Cooper, PhD
Senior Epidemiologist
US Environmental Protection Agency
Washington, DC
David Fiorentino, MD, PhD   David Fiorentino, MD, PhD
Associate Professor of Dermatology
Stanford University School of Medicine
Stanford, CA
Emily Baechler Gillespie, PhD   Emily Baechler Gillespie, PhD
Assistant Professor of Medicine
University of Minnesota
Minneapolis, MN
Dafna D. Gladman, MD   Dafna D. Gladman, MD
Professor
University of Toronto
Toronto, Ontario, Canada
Mariana J. Kaplan, MD   Mariana J. Kaplan, MD
Associate Professor of Internal Medicine, Division of Rheumatology
University of Michigan Medical School
Ann Arbor, MI
  Jorge Sánchez-Guerrero, MD
Head, Division of Rheumatology
Mount Sinai Hospital
Toronto, Ontario, Canada
Betty P. Tsao, PhD   Betty P. Tsao, PhD
Professor of Medicine
UCLA School of Medicine
Department of Medicine
Los Angeles, CA

Our national research program, Bringing Down the Barriers™, supports a robust variety of lupus research grant programs for both students and professors. The Foundation's yearly request for applications focuses on gaps and current needs in lupus research, including recent foci in the following areas: pediatrics, male lupus, adult stem cell transplantation, and mid-to-late stage translational research.